Тритайс 2.5 мг

País: Israel

Língua: russo

Origem: Ministry of Health

Ingredientes ativos:

RAMIPRIL 2.5 MG

Disponível em:

SANOFI - AVENTIS ISRAEL LTD

Código ATC:

C09AA

Forma farmacêutica:

TABLETS

Via de administração:

PER OS

Fabricado por:

SANOFI - AVENTIS S.P.A., ITALY

Grupo terapêutico:

ACE INHIBITORS, PLAIN

Indicações terapêuticas:

Hypertension congestive heart failure reduction of mortality in patients after MI with left ventricular dysfunction. For reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous MI unstable angina or multivessel CABG or multivessel PTCA) stroke or peripheral vascular disease. Also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmHg or diastolic pressure > 90 mmHg) high total cholesterol (>5.2 mmol/L) low HDL ( <0.9 mmol/L) current smoker known microalbuminuria clinical evidence of previous vascular disease. Prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

Data de autorização:

2012-01-01